1. Introduction
===============

*Staphylococcusaureus* infections range from common skin infections, such as furunculosis and impetigo, to severe deep-seated infections. *S*. *aureus* ranks first or second among bacterial pathogens causing bloodstream infections. It is the leading cause of nosocomial pneumonia and it also causes infections of surgical wounds and prosthetic implants. Clinical isolates of methicillin-resistant *Staphylococcus aureus*(MRSA) have become the most common cause of infections among pathogenic bacteria around the Globe, and many life-threatening diseases such as endocarditis, pneumonia and toxin shock syndrome are ascribed to them. Contrary to methicillin-susceptible *S*. *aureus*(MSSA), MRSA tend to be multi-drug resistant (MDR), that is, resistant not only to β-lactam antibiotics but also to a wide range of different antibiotic classes, such as fluoroquinolones, tetracyclines, macrolides, lincosamides and aminoglycosides, and even strains of vancomycin intermediate susceptible or full resistant (VISA and VRSA, respectively) have emerged \[[@B1-molecules-17-02955]\]. Therefore, the search for novel anti-MRSA agents is urgently needed. Meanwhile, great emphasis has been placed on the value of plants used in ethnomedicine and traditional medicine for drug discovery has currently been laid greater stress worldwide \[[@B2-molecules-17-02955],[@B3-molecules-17-02955],[@B4-molecules-17-02955],[@B5-molecules-17-02955]\].

Traditional Chinese medicines (TCM), like Ayurveda, Unani and Kampo, have flourished as systems of medicine in use for thousands of years \[[@B2-molecules-17-02955]\]. With more than 5,000 years of Chinese history and as a part of Chinese culture, TCM mainly used plant materials in organized traditional medical systems which have been playing a critical role in fighting various diseases and maintaing human health. Thousands of Chinese herbal medicines have been recorded in a great variety of national and local literatures such as *Shen Nong*'*s Materia* *Medica* \[[@B6-molecules-17-02955]\], *Compendium of Materia Medica* \[[@B7-molecules-17-02955]\], *Dictionary of Chinese Materia Medica* \[[@B8-molecules-17-02955]\], *Chinese Materia Medica* \[[@B9-molecules-17-02955]\], *Compilation of Chinese Herbal Medicine* \[[@B10-molecules-17-02955]\] and *Selected Yunnan Traditional Chinese Herbs* \[[@B11-molecules-17-02955]\] from ancient to modern times. They have been widely used throughout the country or in local areas by the Chinese people of all nationalities.

In TCM clinical practice, the Chinese disease name "*Chuang-Yang*" (pyogenic infection and ulceration of skin) is a general terminology for the surgical and skin disease visible over the body surface and dermatosis, including "*Yong Ju*, *Ding-Chuang*, *Jie-Zhong*, *Liu-Zhu*, *Liu-Tan*, *etc.*" (carbuncle, deep-seated sore, furuncle, multiple abscess, tuberculosis of bone and joint, scrofula, *etc*.). The diseases are commonly seen in clinic, due to stagnation of *qi* and blood stasized from the attack of *evils* and consumption of blood by *heat-evil* \[[@B12-molecules-17-02955]\].

Many Chinese herbal medicines (or medicinal plants) have been documented as treatment of these diseases, which prompted us to investigate their inhibitory activity against MRSA. We herein report the *in vitro* anti-MRSA effects of a collection of 30 Chinese medicinal plants with reference to the treatment record of skin and other kinds of infections ([Table 1](#molecules-17-02955-t001){ref-type="table"}).

molecules-17-02955-t001_Table 1

###### 

Traditional indications and phytohemical constitution of the 30 Chinese plants.

  No.   Species               Traditional Indication                                                                                                                                                                          Phytohemical Constitution
  ----- --------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------
  1     *A*. *nepalensis*     bleeding of the nose, enteritis and dysentery                                                                                                                                                   tannins, triterpenoids, flavonoids, phenols
  2     *B*. *balsamifer*     anti-rheumatism, ringworm and sores, dysentery, detoxification and snake bite                                                                                                                   flavonoids, simple terpenoids
  3     *B*. *hancei*         heat clearing and detoxicating, dysentery, jaundice, boils, swelling, tuberculosis injury hematemesis, osteomyelitis, periostitis, rheumatism and pain                                          hydroxytyrosol derivatives and glycosides
  4     *C*. *austroglauca*   astringing sores, carbuncles, dysentery, hemostasis and vaginal discharge                                                                                                                       none
  5     *C*. *japonica*       carbuncles, boils, mumps, erysipelas, rheumatism, jaundice, dysentery, hematuria and gonorrhea                                                                                                  flavonoids (delphinidin glycosides)
  6     *C*. *orbiculatus*    dysentery, multiple abscess, Herpes zoster, detoxification, inflammatory, cellulites and snake bite                                                                                             sesquiterpene, flavonoids
  7     *C*. *orchioides*     diarrhea, ulcer, pus and muscles atrophy                                                                                                                                                        triterpenoids, lignans, flavonoids, alkaloids, stereoids
  8     *C*. *prainii*        antipyresis, diuretic and chyluria                                                                                                                                                              alkaloids, polyphenols, flavonoids
  9     *E*. *Burm*           heat clearing and detoxicating, pharyngitis, dysentery, diarrhea, furuncle ulcer, skin itching, swelling and pain of hemorrhoids, throat red and swollen, bleeding gums and traumatic injury.   quinones, triterpenoids, flavonoids
  10    *E*. *daneillii*      diarrhea, abdominal pain and vomiting                                                                                                                                                           alkaloids, flavonoid glycosides, flavaprin, limonoids
  11    *E*. *fortunei*       chronic diarrhea, dysentery, dispersing blood stasis and traumatic bleeding                                                                                                                     alkaloids, triterpenoids, flavonoids
  12    *E*. *laxiflorus*     pesticide, rheumatism, bone fractures and hemoptysis                                                                                                                                            alkaloids, triterpenoids, flavonoids, sesquiterpenes (agarofurans)
  13    *G*. *morella*        wound rot, carbuncle, tinea, ulcer and sore, anthelminthic and containing toxic substances                                                                                                      phenols (gambogic acid), flavonoids (xanthones), triterpenoids
  14    *I*. *simonsii*       scabies, bladder hernias, mixed cropping of edible spices and containing toxic substances                                                                                                       terpenoids, lignans, flavonoids, phenols
  15    *K*. *angustifolia*   anti-infection, swelling and pain, ulcer and enteritis and heat stroke                                                                                                                          lignans, triterpenoids
  16    *L*. *lancifolia*     stomach pain, vomiting and swelling                                                                                                                                                             alkaloids, terpenoids, flavonoids, essential oils
  17    *M*. *hongheensis*    vomiting, diarrhea, dysentery, constipation and geriatric hacking cough                                                                                                                         alkaloids
  18    *M*. *salicina*       carbuncle, furunculosis and sore pain                                                                                                                                                           alkaloids, lignans
  19    *M*. *squamulata*     scabies, carbuncle boils swollen poison, hemorrhoids, enterobiasis, beriberi, rheumatoid and snake bite                                                                                         triterpenoids
  20    *M*. *yunnanensis*    hepatitis, sore, otitis media, stomach and duodenal ulcer, enlarged spleen and boils swelling, hematuria leucorrhea and traumatic bleeding                                                      Polyphenols,tannins，flavonoids,coumarins, various terpenoids
  21    *O*. *javanica*       lump in the abdomen, boils and swelling of throat and containing toxic substances                                                                                                               falcarindiol, carotatoxin, 5-allylpyrogallol
  22    *P*. *edulis*         (no record)                                                                                                                                                                                     unsaturated organic acids
  23    *P*. *molle*          carbuncle, swollen abscess, fistula and scrofula                                                                                                                                                tannins, flavonoids, alkaloids
  24    *R*. *japonicus*      subsiding swelling, jaundice, malaria lymph node tuberculosis and pterygium                                                                                                                     lactones (anemonin, protoanemonin), flavonoids
  25    *S*. *arborescens*    HBV (skimmianine), rheumatoid, paralysisa, beriberi, and containing toxic substances                                                                                                            alkaloids, coumarins, triterpenoids, phenols
  26    *S*. *davidii*        antipyretic, detoxicate, subsiding swelling, laryngitis, pneumonia, dysentery, cystitis and edema                                                                                               polyphenols
  27    *S*. *parasitica*     anti-rheumatism and anticancer                                                                                                                                                                  flavonoids
  28    *S*. *sinensis*       furuncle and swelling                                                                                                                                                                           benzoquinone, tannins, phenols, lignans, flavonoids, triterpenoids
  29    *S*. *tamariscina*    inflammation, pharyngolaryngitis and bacteriostasis                                                                                                                                             flavonoids, phenol glycosides, trehalose
  30    *S*. *viridis*        urticaria, herpes zoster, rheumatism and analgesia                                                                                                                                              lignans, triterpenoids, organic acids

2. Results and Discussion
=========================

2.1. Results
------------

[Table 1](#molecules-17-02955-t001){ref-type="table"} shows the recorded TCM indications and phytohemical constitution of the 30 Chinese medicinal plants \[[@B6-molecules-17-02955],[@B7-molecules-17-02955],[@B8-molecules-17-02955],[@B9-molecules-17-02955],[@B10-molecules-17-02955],[@B11-molecules-17-02955]\]. The antibacterial susceptible spectrum of the tested seven MRSA strains is listed in [Table 2](#molecules-17-02955-t002){ref-type="table"}. The initial screening results of the 30 plant extracts against MSSA and other conventional standard strains of *Escherichia coli* (ATCC 25922), *Pseudomonas aeruginosa*(ATCC 27853) and *Candida albicans*(ATCC Y0109) are expressed as inhibition zone diameters (IZDs) in [Table 3](#molecules-17-02955-t003){ref-type="table"}, while anti-MRSA activities of the selected 21 extracts which were active with IZDs ≥10 mm against MSSA were shown in [Table 4](#molecules-17-02955-t004){ref-type="table"}. Their corresponding MICs/MBCs (µg/mL) are shown in [Table 5](#molecules-17-02955-t005){ref-type="table"}.
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###### 

The antibacterial agent-susceptibility test results of MRSA strains.

  MRSA Strains   Resistant (R)                                        Intermediate (I)   Susceptible (S)
  -------------- ---------------------------------------------------- ------------------ --------------------------------
  MRSA 008       PEN, OXS, AMP, LEV, CTX, PIP/S, ERY, CLI, AZM, RIF   NONE               VAN, TEC, LNZ, FOS,
  MRSA 082       AMP, CLI, RIF, CTX V, CIP, LEV, CAZ                  FOS                LNZ, VAN
  MRSA 092       AZM, OXS, AMP, FOX, CLI, CLR, LEV                    NONE               COT, RIF, PIP/S, VAN, GAT, FOS
  MRSA 123       PEN, OXS, FOX, IPM CTS                               NONE               LNZ, VAN, MXF, FOS
  MRSA 144       PEN, AMP, OXS, FOX, FUR, CFZ, AZM, RIF, CLI, CLR     NONE               VAN, FOS
  MRSA 189       PEN, OXS, AMP, FOX, FUR, CTX, COT, CIP, LEV          FOS                VAN, LNZ, MXF
  MRSA 321       CLR, CLI, AZM, PEN, OXS, AMP, ERY. CTX, FUR, LEV     CAT                VAN, GAT, PIP/T

AMP: ampicillin; AZM: azithromycin; CAT: cefathiamidine; CAZ: ceftazidime; CFZ: cefazolin; CIP: ciprofloxacin; CLI: clindamycin; CLR: clarithromycin; COT: Cotrimoxazole; CTS: cilastatin sodium; CTX: Cefotaxime; ERY: erythromycin; FOS: fosfomycin; FOX: cefoxitin; FUR: cefuroxime; GAT: gatifloxacin; IPM: imipenem; LEV: levofloxacin; LNZ: linezolid; MXF: moxifloxacin; OXS: oxacillin; PEN: Penicillin; PIP: piperacillin; PIP/S: piperacillin/sulbactam; PIP/T: piperacillin/tazobactam; RIF: rifampin; TEC: teicoplanin; VAN: Vancomycin.
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###### 

Screening results of the antimicrobial activities of the extracts from 30 Chinese medicinal plants (IZD: mm) ^a^.

  No.   Species               Part ^b^   Weight (g) ^c^   Ratio (%) ^d^   SA ^e^   EC ^f^   PA ^g^   CA ^h^
  ----- --------------------- ---------- ---------------- --------------- -------- -------- -------- --------
  1     *A*. *nepalensis*     TBL        3.85             7.7             14       \<8      12       9
  2     *B*. *balsamifer*     WP         0.61             1.2             12       9        \<8      5
  3     *B*. *hancei*         WP         4.96             9.9             19       10       13       11
  4     *C*. *austroglauca*   TBL        1.50             3.0             23       14       15       9
  5     *C*. *japonica*       V          1.57             3.1             9        11       13       8
  6     *C*. *orbiculatus*    V          2.06             4.1             11       10       \<8      10
  7     *C*. *orchioides*     WP         2.28             4.6             16       13       14       8
  8     *C*. *prainii*        WP         1.96             3.9             10       10       \<8      9
  9     *E*. *Burm*           L          3.03             6.1             10       10       10       \<8
  10    *E*. *daneillii*      TBL        2.52             5.0             18       12       10       9
  11    *E*. *fortunei*       V          4.42             8.8             15       13       12       11
  12    *E*. *laxiflorus*     TBL        2.68             5.4             \<8      \<8      \<8      10
  13    *G*. *morella*        WP         7.38             14.8            17       12       \<8      \<8
  14    *I*. *simonsii*       TBL        3.48             7.0             13       11       11       8
  15    *K*. *angustifolia*   TBL        0.99             2.0             \<8      8        \<8      8
  16    *L*. *lancifolia*     TBL        2.28             4.6             \<8      \<8      \<8      \<8
  17    *M*. *hongheensis*    TBL        3.09             6.2             21       11       13       \<8
  18    *M*. *salicina*       TBL        2.91             5.8             12       9        8        10
  19    *M*. *squamulata*     TBL        1.48             2.9             17       12       12       11
  20    *M*. *yunnanensis*    TBL        2.91             5.8             24       12       \<8      9
  21    *O*. *javanica*       WP         2.65             5.3             \<8      8        \<8      \<8
  22    *P*. *edulis*         TBL        4.49             9.0             \<8      \<8      \<8      \<8
  23    *P*. *molle*          WP         2.99             6.0             11       10       16       12
  24    *R*. *japonicus*      WP         5.24             10.5            \<8      9        8        \<8
  25    *S*. *arborescens*    TBL        1.86             3.7             24       13       14       11
  26    *S*. *davidii*        TBL        2.54             5.1             \<8      8        9        10
  27    *S*. *parasitica*     TBL        1.04             2.1             \<8      \<8      \<8      \<8
  28    *S*. *sinensis*       TBL        6.49             13.0            18       8        13       21
  29    *S*. *tamariscina*    WP         4.44             8.9             12       9        11       9
  30    *S*. *viridis*        V          2.63             5.3             12       \<8      \<8      9

^a^ IZD: Inhibition zone diameter (the concentration of the extract at 50 mg/mL); ^b^ Part: The part of plant used for extraction (L: leaves; TBL: tender branches and leaves; WP: whole plant; V: vane); ^c^ Weight: The weight of extract; ^d^ Ratio: The ratio of extract; ^e^ SA: *Staphylococcus aureus* (ATCC 25923, MSSA); ^f^ EC: *Escherichia coli* (ATCC 25922); ^g^ PA: *Pseudomonas aeruginosa*(ATCC 27853); ^h^ CA: *Candida albicans*(ATCC Y0109).
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###### 

Comparison of IZDs of the 21 extracts against MRSA and MSSA strains (IZD: mm) ^a^.

  No.   Extracts            MSSA   MRSA~ave~ ± SEM (n) ^b^   △(MSSA-MRSA~ave~)
  ----- ------------------- ------ ------------------------- -------------------
  1     *M. yunnanensis*    24     17.5 ± 1.04 (4)           6.5
  2     *S. arborescens*    24     18.8 ± 2.06 (4)           5.2
  3     *C. austroglauca*   23     18.5 ± 1.85 (4)           4.5
  4     *M. hongheensis*    21     15.8 ± 1.65 (4)           5.2
  5     *B. hancei*         19     16.0 ± 1.63 (4)           3.0
  6     *S. sinensis*       18     14.3 ± 1.31 (4)           3.7
  7     *E. daneillii*      18     13.8 ± 1.31 (4)           4.2
  8     *M. squamulata*     17     14.5 ± 0.87 (4)           2.5
  9     *G. morella*        17     15.7 ± 0.67 (3)           1.3
  10    *C. orchioides*     16     17.3 ± 0.95 (4)           −1.3
  11    *E. fortunei*       15     15.5 ± 1.55 (4)           −0.5
  12    *A. nepalensis*     14     17.0 ± 1.41 (4)           −3.0
  13    *I. simonsii*       13     12.8 ± 1.11 (4)           0.2
  14    *B. balsamifer*     12     7.0 ± 1.22 (4)            5.0
  15    *S. viridis*        12     11.0 ± 1.68 (4)           1.0
  16    *S. tamariscina*    12     11.0 ± 1.00 (4)           1.0
  17    *M. salicina*       12     9.7 ± 0.33 (3)            2.3
  18    *P. molle*          11     15.8 ± 1.38 (4)           −4.8
  19    *C. orbiculatus*    11     9.5 ± 0.50 (4)            1.5
  20    *E. Burm*           10     13.0 ± 2.08 (3)           −3.0
  21    *C. prainii*        10     9.0 ± 1.00 (2)            1.0

^a^ IZD: Inhibition zone diameter (the concentration of the extract at 50 mg/mL); ^b^ Number of MRSA isolates.
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###### 

Anti-MRSA activity of the extracts to the zone of inhibition against MSSA ≥10 mm (MIC/MBC: μg/mL).

  No.   Extracts and Vancomycin   Activity   MSSA      MRSA 082   MRSA 092   MRSA 189   MRSA 144   MRSA 321
  ----- ------------------------- ---------- --------- ---------- ---------- ---------- ---------- ----------
  1     *M*. *yunnanensis*        MIC        32        8          32         64         16         32
  MBC   128                       64         256       128        64         256                   
  2     *S*. *arborescens*        MIC        64        64         64         64         16         32
  MBC   256                       256        256       256        128        128                   
  3     *C*. *austroglauca*       MIC        64        64         64         64         32         16
  MBC   256                       128        512       256        128        256                   
  4     *M*. *hongheensis*        MIC        32        128        8          32         16         16
  MBC   128                       512        32        128        64         64                    
  5     *B*. *hancei*             MIC        64        64         32         64         32         64
  MBC   128                       256        256       128        128        256                   
  6     *E*. *daneillii*          MIC        32        32         32         32         32         64
  MBC   64                        256        128       256        256        256                   
  7     *S*. *sinensis*           MIC        32        64         32         32         32         16
  MBC   128                       256        256       64         128        64                    
  8     *G*. *morella*            MIC        32        32         64         32         16         32
  MBC   256                       256        256       128        64         128                   
  9     *M*. *squamulata*         MIC        64        32         64         32         64         32
  MBC   256                       128        256       128        256        128                   
  10    *C*. *orchioides*         MIC        512       256        512        512        512        256
  MBC   1,024                     1,024      \>2,048   \>2,048    512        1024                  
  11    *E*. *fortunei*           MIC        512       512        512        512        512        512
  MBC   \>2,048                   \>2,048    1,024     \>2,048    \>2,048    \>2,048               
  12    *A*. *nepalensis*         MIC        1024      512        256        512        512        256
  MBC   \>2,048                   1,024      1,024     \>2,048    \>2,048    1,024                 
  13    *I*. *simonsii*           MIC        512       512        512        1,024      1,024      1,024
  MBC   1,024                     \>2,048    \>2,048   \>2,048    \>2,048    \>2,048               
  14    *B*. *balsamifer*         MIC        256       256        256        64         256        128
  MBC   1,024                     256        1,024     256        1,024      256                   
  15    *M*. *salicina*           MIC        512       512        1,024      512        512        512
  MBC   1,024                     \>2,048    \>2,048   \>2,048    1,024      \>2,048               
  16    *S*. *viridis*            MIC        256       128        64         128        128        128
  MBC   1,024                     512        256       512        512        512                   
  17    *S*. *tamariscina*        MIC        512       1,024      1,024      1,024      1,024      1,024
  MBC   1,024                     \>2,048    \>2,048   2,048      \>2,048    \>2,048               
  18    *C*. *orbiculatus*        MIC        1,024     1,024      512        512        1,024      512
  MBC   \>2,048                   \>2,048    1,024     1,024      \>2,048    1,024                 
  19    *P*. *molle*              MIC        512       256        256        256        256        256
  MBC   \>2,048                   1,024      1,024     1,024      1,024      1,024                 
  20    *C*. *prainii*            MIC        1,024     1,024      1,024      1,024      1,024      2,048
  MBC   \>2,048                   \>2,048    2,048     \>2,048    \>2,048    \>2,048               
  21    *E*. *Burm*               MIC        512       512        1,024      1,024      1,024      1,024
  MBC   \>2,048                   1,024      \>2,048   \>2,048    \>2,048    \>2,048               
  /     Vancomycin                MIC        1         1          1          1          1          1
  MBC   2                         2          2         2          2          2                     

2.2. Discussion
---------------

A collection of 30 Chinese medicinal plants were evaluated for their *in vitro* antimicrobial effects, especially their anti-MRSA potentials. Most of the plants with anti-infective effects related to skin infections have been indicated in various works of Chinese herbal medicines either by themselves or the different species belonging to the same botanical genus, such as the indication of carbuncle which means a severe abscess or multiple boil in the skin, typically infected with *S*. *bacteria* ([Table 1](#molecules-17-02955-t001){ref-type="table"}) \[[@B6-molecules-17-02955],[@B7-molecules-17-02955],[@B8-molecules-17-02955],[@B9-molecules-17-02955],[@B10-molecules-17-02955],[@B11-molecules-17-02955]\]. The antimicrobial screening of all the plant species is being reported for the first time to the best of our knowledge, especially the anti-MRSA activities.

The 80% ethanol extracts of the 30 Chinese medicinal plant extracts were initially subjected to the screening of their antimicrobial activities against MSSA and other conventional standard strains of *Escherichia coli* (ATCC 25922), *Pseudomonas aeruginosa*(ATCC 27853) and *Candida albicans*(ATCC Y0109). Their activities as IZDs (mm) at a concentration of 50 mg/mL ranged from \<8 to 24, of which 21 extracts showed IZDs ≥10 mm against MSSA ([Table 1](#molecules-17-02955-t001){ref-type="table"}). The results were in agreement with the literature record of traditional usages ([Table 3](#molecules-17-02955-t003){ref-type="table"}) \[[@B6-molecules-17-02955],[@B7-molecules-17-02955],[@B8-molecules-17-02955],[@B9-molecules-17-02955],[@B10-molecules-17-02955],[@B11-molecules-17-02955]\]. Judging from the IZD values, the extracts were generally more active against the Gram positive pathogen (MSSA) than against Gram negative (*E*. *coli* and *P*. *aeruginosa*) and fungal pathogens (*C*. *albicans*). The additional permeability barrier caused by the outer lipopolysaccharide layer in Gram negative bacteria makes them more resistant to plant natural products, as has been demonstrated previously \[[@B13-molecules-17-02955],[@B14-molecules-17-02955]\]. Therefore, finding out anti-staphylococcal natural products from plant materials is much easier and is proved in the previous reports \[[@B15-molecules-17-02955],[@B16-molecules-17-02955],[@B17-molecules-17-02955],[@B18-molecules-17-02955]\].

The tested MRSA strains were seven multi-drug resistant clinical isolates ([Table 2](#molecules-17-02955-t002){ref-type="table"}). They were used for the further assay of their susceptibilities to the 21 extracts ([Table 4](#molecules-17-02955-t004){ref-type="table"}). It is interesting that these extracts which were active against MSSA also showed more or less activity against MRSA with IZD values (mm) ranging between 9.0 and 18.8 and this has been noted previously \[[@B15-molecules-17-02955],[@B16-molecules-17-02955],[@B17-molecules-17-02955],[@B18-molecules-17-02955],[@B19-molecules-17-02955]\]. The differences were from −3.0 to 6.5 mm in this study ([Table 4](#molecules-17-02955-t004){ref-type="table"}).

Anti-MRSA potency of MICs/MBCs (μg/mL) of the 21 extracts was determined as 8-2,048/32-\>2,048 ([Table 5](#molecules-17-02955-t005){ref-type="table"}). Comparison of the values of IZD and MIC for a same extract in [Table 4](#molecules-17-02955-t004){ref-type="table"} and [Table 5](#molecules-17-02955-t005){ref-type="table"}, they were not always positively correlated. As different sample concentrations will produce different IZDs, the real inhibitory potency of a sample should be judged by its MIC. This should be noted for future studies.

From the phytochemical constitution of the 30 plant materials listed in [Table 1](#molecules-17-02955-t001){ref-type="table"}, it is found that most of the active extracts contained tannins, (poly)phenols (including flavonoids, lignans and coumarins), terpenoids or alkaloids which have been reported \[[@B18-molecules-17-02955],[@B20-molecules-17-02955],[@B21-molecules-17-02955],[@B22-molecules-17-02955],[@B23-molecules-17-02955],[@B24-molecules-17-02955],[@B25-molecules-17-02955]\].

The phytochemicals, including polyphenols and antimicrobial activity of *Mallotus* species have been reviewed \[[@B26-molecules-17-02955],[@B27-molecules-17-02955]\]. Rottlerin from *M*. *philippinensis* exhibited potent bactericidal activity with an MBC value of 3.12--6.25 μg/mL against several clinical *H. pylori* isolates \[[@B28-molecules-17-02955]\]. *Garcinia* genus is rich in caged xanthones \[[@B29-molecules-17-02955]\]. Morellin isolated from gamboge (*G*. *hanburyi*,tenghuang in Chinese) was reported as an antibiotic principle in 1954 \[[@B30-molecules-17-02955]\]. The anti-MRSA activity of morellin and other caged xanthones from Gamboge, *G*. *morella* and other *Garcinia* species have also reported \[[@B31-molecules-17-02955],[@B32-molecules-17-02955]\]. Two antifungal compounds ulopterol (a coumarin) and a quinolone alkaloid 4-Methoxy-l-methyl-3-(2\'-S-hydroxy-3\'-ene-butyl)-2-quinolone were isolated from *Skimmia laureola*, a Pakistani medicinal plant \[[@B33-molecules-17-02955]\], which were similar to our results of the inhibition of *S. arborescens* against *C. albicans* ([Table 3](#molecules-17-02955-t003){ref-type="table"}). However, no active antimicrobial compounds from the other plant materials have been isolated up to now, especially the anti-MRSA compounds from the most active extracts of *S*. *sinensis*, *E*. *daneillii*, *M*. *squamulata*, and *B*. *hancei*, with MICs at 8--64 μg/mL. We are continuing our search for the corresponding phytochemicals from these plants and their further systematic anti-MRSA properties.

3. Experimental
===============

3.1. Plant Materials
--------------------

The selected 30 Chinese medicinal plant samples were collected from the tropical mountain forests of southeastern Yunnan Province of China, at altitudes of 1,500--3,074 m in June 2010. They were identiﬁed by Y.M. Shui at the Kunming Institute of Botany (KIB); the Chinese Academy of Sciences. Voucher specimens are preserved at the herbarium of KIB \[[@B34-molecules-17-02955]\]. The names of species/family (specimen No.) were as the following: *Alnus nepalensis* D. Don./Betulaceae (KUN 35); *Blumea balsamifer* (Linn.) D.C./Asteraceae (KUN 21); *Brandisia hancei* Hook. f./Scrophulariaceae (YFS 6); *Carex prainii* C.B. Clarke/Cyperaceae (KUN 11133); *Cayratiy japonica*(Thunb) Gngacp.var.*japonica*/Vitaceae (YFS 531); *Celastrus orbiculatus* Thunb./Celastraceae (KUN 110); *Curculigo orchioides*Gaertn./Hypoxidaceae (KUN 1151); *Cyclobalanopsis austroglauca*Y.T. Chang/Fagaceae (SWFC 851222); *Embelia* Burm f./Myrsinaceae (KUN355); *Euonymusfortunei* (Turcz.); Hand. Mazz./Celastraceae (YUKU (s.n)); *Euonymus laxiflorus* Charmp.ex.Benth./Celastraceae (YCP 851027); *Evodia daneillii*(Benn) Hemsl./Rutaceae (YFS 663); *Garcinia morella* Desr./Clusiaceae (YCP 851757); *Illicium simonsii* Maxim./Il1iciaceae (IBSC 125); *Kadsura* angustifolia A.C. Smith/Schisandraceae (KUN 4480); *Litsea lancifolia* (Roxb. ex. Nees); Benth. et. Hook. f. ex. F./Lauraceae (KUN 23); *Machilus salicina* Hance./Lauraceae (YUKU 1535); *Mallotusyunnanensis*Pax et. Hoffm./Euphorbiaceae (YFS 1144); *Manglietia hongheensis*Y.m Shui et. W.H. Chen./Magnoliaceae (KUN 262); *Meliosma squamulata* Hance./Lauraceae (KUN 2411); *Oenanthe javanica* (Bl.)DC./Umbellifera (KUN 214); *Polygonummolle* D. Don./Polygonaceae (KUN 367); *Pyrularia edulis* (Wall.) A.D.C./Santalaceae (KUN 60002100); *Ranunculus japonicus* Thumb./Ranunculaceae (KUN 2398); *Schima sinensis* (Hemsl. et. Wils) Airy-shaw./Theaceae (KUN158); *Schisandra viridis* A.c.Smith./Schisandraceae (YFS); *Scurrula parasitica*Linn.var. *parasitica*./Loranthaceae (YFS 327); *Selaginella tamariscina* (Seauv.) Spring./Selaginellaceae (YCP 85937); *Skimmia arborescens* Anders./Rutaceae (PE 100260); *Sophora davidii*(Franch.) Skeels./Leguminosae (YCP 851049). The traditional indications and phytochemical constitutions were listed in [Table 1](#molecules-17-02955-t001){ref-type="table"}.

3.2. Microbial Strains and Culture Media
----------------------------------------

Standard bacterial and fungal strains, *i.e*., *Staphylococcus aureus* (ATCC 25923, MSSA), *Escherichia coli* (ATCC 25922), *Pseudomonas aeruginosa*(ATCC 27853) and *Candida albicans*(ATCC Y0109) were provided by the National Institute for the Control of Pharmaceutical and Biological Products (NICPBP, China). Clinical MDR MRSA strains of MRSA 8, MRSA 82, MRSA 92, MRSA 123, MRSA 144, MRSA 189 and MRSA 321 were clinical isolates from infectious samples of critically ill patients in Kunming General Hospital (KGH). Pathogen puriﬁcation and identiﬁcation (including colonial morphology, Gram staining and coagulase testing) were conducted in our clinical microbiology laboratory and further conﬁrmed by standard cefoxitin disk diffusion test following the Clinical and Laboratory Standards Institute (CLSI) guidelines \[[@B15-molecules-17-02955],[@B35-molecules-17-02955],[@B36-molecules-17-02955]\]. ATCC 25923 was used as the control strain. Vancomycin (Eli Lilly Japan K.K., Seishin Laboratories) was used as a control anti-MRSA agent. Standard Mueller-Hinton agar and broth (MHA and MHB) and Sabouraud agar (Tianhe Microbial Agents Co., Hangzhou, China) were used as the bacterial and fungal culture media, respectively. The antibacterial agents-susceptibility testing results of MRSA strains were shown in [Table 2](#molecules-17-02955-t002){ref-type="table"}.

3.3. Extract Preparation
------------------------

The 30 samples of the air-dried and ground plant materials (50 g) were macerated with 80% ethanol (500 mL) for 7 days, ﬁltered and the mare was further macerated twice with the same solvent overnight and ﬁltered after being sonicated for 30 min. The ﬁltrates were combined and the solvent was evaporated at 40 °C in vacuum to afford each of the plant extract ([Table 3](#molecules-17-02955-t003){ref-type="table"}).

3.4. Antimicrobial Screening
----------------------------

The ethanol extracts of the 30 plants were primarily subjected to susceptibility screening against standard microbial strains according to the agar diffusion method on MHA (for the bacteria) or SA (for *C*. *albicans*) plates. The sample extracts (50 mg/mL in dimethyl sulfoxide) were pipetted into 6 mm (in diameter) holes punched in the agar of prepared agar plates, plating with inoculums of 1.5 × 10^8^ CFU/mL for bacteria and 5 × 10^5^ CFU/mL for *C*. *albicans* in advance, respectively and incubated at 35 °C (for *C*. *albicans* at 28 °C) for 24 h, measured and recorded the IZDs \[[@B15-molecules-17-02955],[@B16-molecules-17-02955],[@B17-molecules-17-02955],[@B37-molecules-17-02955]\]. The solvent value was deducted accordingly to get ﬁnal results of activity. All experiments were carried out in triplicate. The test results were interpreted based on IZD as \<10 mm for the resistance, =10 mm for the mildly susceptible, 11--15 mm for moderately susceptible, ≥16 mm for the highly susceptible ([Table 2](#molecules-17-02955-t002){ref-type="table"}). The 21 extracts with IZDs ≥10 mm against MSSA were further subjected to the assay of their IZDs against MRSA strains ([Table 3](#molecules-17-02955-t003){ref-type="table"}).

3.5. MICs and MBCs Assaying
---------------------------

The extracts with IZDs ≥10 mm against MSSA were further subjected to the assay of their IZDs and minimal inhibitory concentrations and minimal bactericidal concentrations (MICs/MBCs) against MRSA strains by serial dilution method according to the procedures reported previously \[[@B15-molecules-17-02955],[@B16-molecules-17-02955],[@B17-molecules-17-02955],[@B38-molecules-17-02955],[@B39-molecules-17-02955]\]. Briefly, MICs/MBCs were determined by the standardized broth (using MHB) microdilution techniques with starting inoculums of 5 × 10^5^ CFU/mL for the bacteria according to CLSI (formally NCCLS) guidelines and incubated at 35 °C for 24 h. For the MBCs assaying, 0.1 mL aliquots from drug dilution wells with visual growth inhibition were plated onto MHA media. The lowest drug concentration that yielded three or fewer microorganism colonies was recorded as the MBC. They were determined in triplicate, with concentrations ranging up to 2048 μg/mL for all the extracts ([Table 5](#molecules-17-02955-t005){ref-type="table"}).

4. Conclusions
==============

The screening of *in vitro* antimicrobial activity of the ethanol extracts from 30 Chinese medicinal plants led to the confirmation of 21 extracts displaying both anti-MSSA and MRSA effects with various levels of potency which were in good agreement with their TCM indications of skin infections and modern phytochemical constituents, with *M*. *yunnanensis* and *S*. *arborescens* extracts being the most active against MRSA. The combination of TCM indications and phytochemical profiles is a promising approach to the search of anti-MRSA plant natural products.
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